The FDA has recently approved \u201cSinuva\u201d, a sinus implant to treat nasal polyps.\u00a0 Up to 25% of patients with allergic rhino-sinusitis develop nasal polyps.\u00a0 The polyps can cause nasal discharge, chronic congestion, snoring, tendency to sinus infection and loss of sense of smell.\u00a0 Often the polyps can be treated with nasal steroid sprays and with leukotriene modifier pills such as Singular or Accolate.<\/p>\n
But, for some patient\u2019s surgery is the only option.\u00a0 Unfortunately, in many surgical patients the polyps often regrow.<\/p>\n
Enter Sinuva, a mometasone-eluting sinus implant.\u00a0 Mometasone is a topical steroid found in skin creams, nasal sprays and asthma sprays.\u00a0 The implant is placed, often following nasal polypectomy and left in place to slowly release the mometasone.\u00a0 Research has shown a dramatic reduction in polyp regrowth.\u00a0 The main side effect was bloody nasal discharge.\u00a0 The cost is $1,275 per nostril.<\/p>\n","protected":false},"excerpt":{"rendered":"
The FDA has recently approved \u201cSinuva\u201d, a sinus implant to treat nasal polyps.\u00a0 Up to 25% of patients with allergic rhino-sinusitis develop nasal polyps.\u00a0 The polyps can cause nasal discharge, chronic congestion, snoring, tendency to sinus infection and loss of sense of smell.\u00a0 Often the polyps can be treated with nasal steroid sprays and with leukotriene modifier pills such as Singular or Accolate. But, for some patient\u2019s surgery is the only option.\u00a0 Unfortunately, in many surgical patients the polyps often…<\/p>\n